Solid Biosciences Inc.
NASDAQ:SLDB
5.145 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -124.697 | -96.015 | -85.981 | -72.188 | -88.29 | -117.223 | -74.798 | -53.178 | -23.773 | -6.664 |
| Depreciation & Amortization
| 2.455 | 2.581 | 2.408 | 2.964 | 3.922 | 2.824 | 1.566 | 0.448 | 0.056 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 1.209 | 0 | 0 | 0 | 0.206 | 0.505 | 0 |
| Stock Based Compensation
| 10.519 | 7.625 | 7.537 | 13.373 | 11.629 | 14.207 | 5.955 | 5.33 | 1.47 | 0.764 |
| Change In Working Capital
| 2.85 | -6.337 | -3.689 | -23.041 | 16.16 | 7.755 | -2.834 | 4.429 | 2.785 | 1.588 |
| Accounts Receivables
| 0 | 0 | 0.11 | -0.11 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | -11.502 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 2.205 | -0.764 | -5.246 | 1.209 | -3.431 | 3.779 | -1.61 | 1.579 | 2.213 | 0.585 |
| Other Working Capital
| 0.645 | -5.573 | 1.447 | -12.638 | 19.591 | 3.976 | -1.224 | 2.85 | 0.572 | 1.003 |
| Other Non Cash Items
| 8.861 | -2.034 | -18.252 | -0.081 | -0.02 | -0.277 | -0.086 | -0.459 | -1.163 | 0.108 |
| Operating Cash Flow
| -100.012 | -94.18 | -97.977 | -77.764 | -56.599 | -92.714 | -70.197 | -43.224 | -20.12 | -4.204 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.654 | -1.515 | -3.015 | -1.281 | -0.899 | -4.387 | -7.776 | -2.276 | -0.392 | 0 |
| Acquisitions Net
| 0 | 0 | 31.523 | 89.805 | -7.499 | -24.516 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -204.337 | -117.428 | -182.762 | -141.249 | -0.401 | -31.496 | -44.321 | -18.897 | -25.695 | -26.806 |
| Sales Maturities Of Investments
| 188.9 | 128.632 | 212.811 | 51.444 | 7.9 | 60.399 | 25.335 | 31.621 | 22.035 | 0 |
| Other Investing Activites
| 0.005 | 0 | 0.6 | -89.805 | 7.499 | 24.516 | -18.986 | 0.1 | -0.165 | -26.806 |
| Investing Cash Flow
| -16.086 | 9.689 | 59.157 | -91.086 | 6.6 | 24.516 | -26.762 | 10.548 | -4.217 | -26.806 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -0.473 | 0 | 2.077 | 0 | 0 | 0 | -0.013 | 0 | 0 | 0 |
| Common Stock Issued
| 127.227 | 2.974 | 72.551 | 134.878 | 132.49 | 49.325 | 133.688 | 79.502 | 3.42 | 51.592 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.794 | 0.148 | 0.203 | 0.107 | -3.79 | 8.55 | -2.168 | 77.078 | 3.42 | 51.592 |
| Financing Cash Flow
| 122.437 | 3.122 | 74.831 | 134.985 | 128.7 | 57.875 | 131.507 | 77.078 | 3.42 | 51.592 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 6.339 | -81.369 | 36.011 | -33.865 | 78.701 | -10.323 | 34.548 | 44.402 | -20.917 | 20.582 |
| Cash At End Of Period
| 82.187 | 74.015 | 157.217 | 121.206 | 155.071 | 76.37 | 86.693 | 52.08 | 7.678 | 28.595 |